{"DataElement":{"publicId":"14673511","version":"1","preferredName":"Confirmation Pathological Diagnosis Type","preferredDefinition":"A description of the confirmed pathological diagnosis.","longName":"14673508v1.00:14673510v1.00","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"14673508","version":"1","preferredName":"Confirmation Pathological Diagnosis","preferredDefinition":"Having been established or verified.:Diagnosis based on a pathological assessment.","longName":"4842531v1.00:14673507v1.00","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"4842531","version":"1","preferredName":"Confirmation","preferredDefinition":"Having been established or verified.","longName":"C25458","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"173BF844-963A-E098-E050-BB89AD431F3E","latestVersionIndicator":"Yes","beginDate":"2015-05-29","endDate":null,"createdBy":"LEEW","dateCreated":"2015-05-29","modifiedBy":"ONEDATA","dateModified":"2015-05-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14673507","version":"1","preferredName":"Pathological Diagnosis","preferredDefinition":"Diagnosis based on a pathological assessment.","longName":"C178004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathological Diagnosis","conceptCode":"C178004","definition":"Diagnosis based on a pathological assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E862A3D-7AE4-36D0-E063-731AD00A58EE","latestVersionIndicator":"Yes","beginDate":"2024-01-09","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2024-01-09","modifiedBy":"TYRRELLM","dateModified":"2024-01-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E862A3D-7AE5-36D0-E063-731AD00A58EE","latestVersionIndicator":"Yes","beginDate":"2024-01-09","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2024-01-09","modifiedBy":"TYRRELLM","dateModified":"2024-01-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14673510","version":"1","preferredName":"Pathological Diagnosis Type","preferredDefinition":"Diagnosis based on a pathological assessment._Something distinguishable as an identifiable class based on common qualities.","longName":"14673510v1.00","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Epithelial Ovarian Carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"2593147","version":"1","preferredName":"Ovarian Carcinoma","longName":"2593147","preferredDefinition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Carcinoma","conceptCode":"C4908","definition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"286E976F-6E43-3730-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0E882D1C-A5D3-3378-E063-731AD00AFF44","beginDate":"2024-01-09","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2024-01-09","modifiedBy":"TYRRELLM","dateModified":"2024-01-09","deletedIndicator":"No"},{"value":"Fallopian Tube Carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"3210700","version":"1","preferredName":"Fallopian Tube Carcinoma","longName":"3210700","preferredDefinition":"A carcinoma arising from the fallopian tube which is attached to the uterine corpus (uterine body). Most patients are postmenopausal, and postmenopausal bleeding is the most frequently seen symptom. Morphologically, the majority of fallopian tube carcinomas are serous or endometrioid adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Carcinoma","conceptCode":"C3867","definition":"A carcinoma arising from the fallopian tube. Most patients are postmenopausal, and postmenopausal bleeding is the most frequently seen symptom. Morphologically, the majority of fallopian tube carcinomas are serous or endometrioid adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9080-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0E882D1C-A5D4-3378-E063-731AD00AFF44","beginDate":"2024-01-09","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2024-01-09","modifiedBy":"TYRRELLM","dateModified":"2024-01-09","deletedIndicator":"No"},{"value":"Primary Peritoneal Carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"4722587","version":"1","preferredName":"Primary Peritoneal Carcinoma","longName":"4722587","preferredDefinition":"A rare carcinoma that arises from the peritoneum and resembles the malignant surface epithelial-stromal tumors that arise from the ovary.  Serous adenocarcinoma is the most common histologic variant. It affects women almost exclusively.  The diagnosis of primary peritoneal carcinoma can be made only if both ovaries are not involved by tumor, or, if the ovaries are involved, the tumor is confined to the ovarian surface without invasion of the ovarian stroma and the peritoneal involvement is greater than the ovarian surface involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Peritoneal Carcinoma","conceptCode":"C40022","definition":"A rare carcinoma that arises from the peritoneum and resembles the malignant surface epithelial-stromal tumors that arise from the ovary.  Serous adenocarcinoma is the most common histologic variant. It affects women almost exclusively.  The diagnosis of primary peritoneal carcinoma can be made only if both ovaries are not involved by tumor, or, if the ovaries are involved, the tumor is confined to the ovarian surface without invasion of the ovarian stroma and the peritoneal involvement is greater than the ovarian surface involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B9DC-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0E882D1C-A5D5-3378-E063-731AD00AFF44","beginDate":"2024-01-09","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2024-01-09","modifiedBy":"TYRRELLM","dateModified":"2024-01-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14673509","version":"1","preferredName":"Pathological Diagnosis Type","preferredDefinition":"Diagnosis based on a pathological assessment._Something distinguishable as an identifiable class based on common qualities.","longName":"14673509v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathological Diagnosis","conceptCode":"C178004","definition":"Diagnosis based on a pathological assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E87A5DF-8E40-18C9-E063-731AD00AC779","latestVersionIndicator":"Yes","beginDate":"2024-01-09","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2024-01-09","modifiedBy":"TYRRELLM","dateModified":"2024-01-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E87A5DF-8E41-18C9-E063-731AD00AC779","latestVersionIndicator":"Yes","beginDate":"2024-01-09","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2024-01-09","modifiedBy":"TYRRELLM","dateModified":"2024-01-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What is the confirmed pathological diagnosis?","url":null,"context":"NRG"},{"name":"NRG Text 1","type":"Alternate Question Text","description":"Does the patient have pathologically (histologically or cytologically) proven diagnosis of:","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E87B678-7109-1BEB-E063-731AD00A09A3","latestVersionIndicator":"Yes","beginDate":"2024-01-09","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2024-01-09","modifiedBy":"TYRRELLM","dateModified":"2024-01-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}